Loading chat...

NJ A538

Bill

Status

Introduced

1/13/2026

Primary Sponsor

Robert Auth

Click for details

Origin

General Assembly

2026-2027 Regular Session

AI Summary

  • Requires all pharmaceutical representatives in New Jersey to obtain a license from the State Board of Medical Examiners before marketing or promoting prescription drugs to practitioners.

  • Applicants must be at least 18 years old, demonstrate good moral character, complete a board-approved professional education course, and pay required fees.

  • Licensed representatives must complete a minimum of 6 hours of continuing education every two years, covering ethics, pharmacology, pharmaceutical marketing laws, opioid drugs, and pain management alternatives.

  • Representatives must report to the board at least every two years: practitioners contacted, frequency and duration of contacts, pharmaceuticals promoted, samples or gifts provided with their values, and any compensation given to practitioners.

  • Prohibits deceptive marketing practices, misrepresenting credentials as licensed healthcare professionals, and attending patient examinations without consent, with violations subject to license suspension or revocation.

Legislative Description

"Pharmaceutical Representative Licensing Act."

Regulated Professions

Last Action

Introduced, Referred to Assembly Regulated Professions Committee

1/13/2026

Committee Referrals

Regulated Professions1/13/2026

Full Bill Text

No bill text available